About
1. Kmieciak M, Worschech A, Nikizad H, Gowda M, Habibi M, Depcrynski A, Wang E, Godder K, Holt SE, Marincola FM, Manjili MH. CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer. Breast Cancer Research and Treatment, May 2010 (epub ahead of publication).
2. Madhu Gowda, Kamar Godder, Maciej Kmieciak, Andrea Worschech, Ena Wang, Fransesco Marincola and Masoud Manjili. The pattern of immune response differs in low-risk vs. high-risk Neuroblastoma. Pediatric Blood & Cancer (ASPHO 23rd annual meeting abstracts), Jun 2010; 54:849.
3. Masoud Manjili, Catherine H Roberts, Maciej Kmieciak, Madhu S Gowda, Andrea Ferreira-Gonzalez, Kellie Archer, Shiyu Song, Harold M Chung, John M. McCarty, and Amir Toor. Oligoclonal T Cells Associated with Gvhd Following Allogeneic Stem Cell Transplantation Conditioned with Thymoglobulin and Reduced Intensity Total Body Irradiation. Blood (ASH Annual Meeting Abstracts), Nov 2009; 114: 4662.
4. Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM, Manjili MH. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med. 2009 Oct 22; 7:89.
5. Madhu Gowda, Anil Kumar, Asadullah Khan, Janice Kuhn, Melinda Nolte, Gita Massey. Vitamin D deficiency in patients with hemophilia. Oral and poster presentation at the annual National hemophilia Foundation conference. Denver, Colorado 11/2008.
Clinical Interests
-
Tumor immunology
Neuroblastoma
Clotting disorders
Long-term survivors of cancer
Education
Residency
Long Island College Hospital
Medical School
Bangalore Medical College, India
Fellowship
Children's Hospital of Richmond at VCU
Locations
Children's Pavilion
1000 East Broad Street
Richmond, VA 23219
Call us at
(804) 828-CHOR (2467)Fredericksburg Multispecialty Center
10528 Spotsylvania Avenue
Fredericksburg, VA 22408
Call us at
(804) 828-CHOR (2467)Ratings & Reviews
Learn more about the Press Ganey Survey
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
Get access to new, innovative care
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Related News
Research, Clinical, Prevention
Cardio-oncology: Protecting the heart health of cancer patients
Feb 20, 2023
Advances in care are leading to better outcomes for cancer patients, but some cancer treatments can lead to negative impacts on the heart and cardiovascular system, including high blood pressure, irregular heartbeats, heart disease and heart failure. For many cancer patients who have completed treatment and are years out from their diagnosis, their risk of death from heart disease can be higher than their risk of death from cancer. The emerging field of cardio-oncology is paving the way for...
